7. Andersson Y, Juell S, Fodstad O (2004) Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti- epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. International journal of cancer 112: 475–483. 8. Natali PG, Giacomini P, Russo C, Steinbach G, Fenoglio C, et al. (1983) Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens. Journal of cutaneous pathology 10: 225–237. 9. Chang CC, Campoli M, Luo W, Zhao W, Zaenker KS, et al. (2004) Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms. Annals of the New York Academy of Sciences 1028: 340–350. 10. Andersson Y, Engebraaten O, Fodstad O (2009) Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. British journal of cancer 101: 1307–1315. 11. Risberg K, Fodstad O, Andersson Y (2009) The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro. International journal of cancer 125: 23–33. 12. Mihic LL, Bulat V, Situm M, Krolo I, Seserko A (2010) The role of apoptosis in the pathogenesis of malignant melanoma. Collegium antropologicum 34 Suppl 2: 303–306. 13. Szegezdi E, Macdonald DC, Ni Chonghaile T, Gupta S, Samali A (2009) Bcl-2 family on guard at the ER. American journal of physiology 296: C941–953. 14. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 435: 677–681. 15. van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, et al. (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer cell 10: 389–399. 16. Xu H, Krystal GW (2010) Actinomycin D decreases Mcl-1 expression and acts synergistically with ABT-737 against small cell lung cancer cell lines. Clin Cancer Res 16: 4392–4400. 17. Inuzuka H, Fukushima H, Shaik S, Liu P, Lau AW, et al. (2011) Mcl-1 ubiquitionation and destruction. Oncotarget 2: 239–244. 18. Mason KD, Vandenberg CJ, Scott CL, Wei AH, Cory S, et al. (2008) In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proceedings of the National Academy of Sciences of the United States of America 105: 17961–17966. 19. Fodstad O, Kjonniksen I (1994) Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. Journal of cellular biochemistry 56: 23–28. 20. Risberg K, Fodstad O, Andersson Y (2010) Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells. J Immunother 33: 272–278. 21. Curry BJ, Smith MJ, Hersey P (1996) Detection and quantitation of melanoma cells in the circulation of patients. Melanoma research 6: 45–54. 22. Zhang XD, Franco A, Myers K, Gray C, Nguyen T, et al. (1999) Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer research 59: 2747–2753. 23. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological reviews 58: 621–681. 9.2.27PE and ABT-737 in Melanoma 24. Han Z, Hendrickson EA, Bremner TA, Wyche JH (1997) A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. The Journal of biological chemistry 272: 13432–13436. 25. Tao W, South VJ, Diehl RE, Davide JP, Sepp-Lorenzino L, et al. (2007) An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Molecular and cellular biology 27: 689–698. 26. Norberg E, Orrenius S, Zhivotovsky B (2010) Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochemical and biophys- ical research communications 396: 95–100. 27. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, et al. (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Molecular cell 6: 1099–1108. 28. Straten P, Andersen MH (2010) The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens. Oncotarget 1: 239–245. 29. Traini R, Ben-Josef G, Pastrana DV, Moskatel E, Sharma AK, et al. (2010) ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol. Molecular cancer therapeutics 9: 2007–2015. 30. Hermanson D, Addo SN, Bajer AA, Marchant JS, Das SG, et al. (2009) Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria. Molecular pharmacology 76: 667–678. 31. Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. The Journal of clinical investigation 115: 2656–2664. 32. Tsai YC, Weissman AM (2010) The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes & cancer 1: 764–778. 33. Decuypere JP, Monaco G, Missiaen L, De Smedt H, Parys JB, et al. (2011) IP(3) Receptors, Mitochondria, and Ca Signaling: Implications for Aging. Journal of aging research 2011: 920178. 34. Rong YP, Barr P, Yee VC, Distelhorst CW (2009) Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. Biochimica et biophysica acta 1793: 971–978. 35. Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, et al. (2005) Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 102: 105–110. 36. Eckenrode EF, Yang J, Velmurugan GV, Foskett JK, White C (2010) Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling. The Journal of biological chemistry 285: 13678–13684. 37. Distelhorst CW, Bootman MD (2010) Bcl-2 interaction with the inositol 1,4,5- trisphosphate receptor: Role in Ca(2+) signaling and disease. Cell calcium. 38. White C, Li C, Yang J, Petrenko NB, Madesh M, et al. (2005) The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nature cell biology 7: 1021–1028. 39. Joseph SK, Hajnoczky G (2007) IP3 receptors in cell survival and apoptosis: Ca2+ release and beyond. Apoptosis 12: 951–968. 40. Hikita H, Takehara T, Shimizu S, Kodama T, Shigekawa M, et al. (2010) The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hepatology Baltimore, Md 52: 1310–1321. 41. Yecies D, Carlson NE, Deng J, Letai A (2010) Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood 115: 3304–3313. PLoS ONE | www.plosone.org 12 September 2011 | Volume 6 | Issue 9 | e24012